Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE3B | Q13370 | 1/20 | 0.37 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.37 |
| ▸ | SQOR | Q9Y6N5 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | PKM | P14618 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.31 |
| ▸ | AR | P10275 | 1/20 | 0.30 |
| ▸ | DHODH | Q02127 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.30 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21917113 | 0.99 | PDE3B (0.37) | PDE3BPDE3ASQORMAPTPKM | |
| SCHEMBL23968861 | 0.89 | ALDH1A1 (0.39) | MAPTALDH1A1GAAFFAR4MEN1 | |
| SCHEMBL21917441 | 0.88 | ALDH1A1 (0.30) | MAPTPKMALDH1A1GAA | |
| SCHEMBL21917288 | 0.88 | PTGDR2 (0.41) | MAPTPKMALDH1A1GAAPDK2 | |
| SCHEMBL23968819 | 0.88 | BACE1 (0.41) | MAPTPKMALDH1A1GAAPTGDR2 | |
| SCHEMBL21917690 | 0.88 | ALDH1A1 (0.38) | MAPTALDH1A1GAAFFAR4MEN1 | |
| SCHEMBL21917313 | 0.88 | BACE1 (0.37) | MAPTPKMALDH1A1GAAFFAR4 | |
| SCHEMBL23969017 | 0.87 | KIF11 (0.30) | — | |
| SCHEMBL23969016 | 0.87 | PTGDR2 (0.40) | MAPTPKMALDH1A1GAAPDK2 | |
| SCHEMBL23969073 | 0.87 | PDE2A (0.39) | MAPTPKMALDH1A1GAAFFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11165025-B2 | Compound and organic electronic element comprising same | LG CHEM, LTD. | 2021-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11165025-B2 | Compound and organic electronic element comprising same | OR10J3, ESR1, ETV6 | PDE3B 4694/4885PDE3A 4777/4885SQOR 752/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.